Guest Contributor

New stroke drug receives $6.6 million for clinical trials

Guest Contributor
September 24, 2014

A new drug designed to contain damage resulting from a stroke will go to Phase III clinical trials with a $6.6-million donation from Brain Canada and its matching fund partners. The clinical trials, dubbed FRONTIER, will cost $10 million and will be conducted by


Other stories mentioning these organizations, people and topics
Organizations: Brain Canada

Other News

London Health Sciences Centre receives $5-M donation

NRC launches program for marine vessel technologies

CCA to examine energy use and climate change

Canada holds steady at 14th in WEF annual ranking






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.